Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer. [electronic resource]
Producer: 20100816Description: 185 p. digitalISSN:- 1471-2407
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- CA-125 Antigen -- blood
- Carboplatin -- administration & dosage
- Carcinoma -- chemistry
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Female
- Gynecologic Surgical Procedures
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Membrane Proteins -- blood
- Middle Aged
- Ovarian Neoplasms -- chemistry
- Randomized Controlled Trials as Topic
- Second-Look Surgery
- Time Factors
- Tissue Array Analysis -- methods
- Tissue Inhibitor of Metalloproteinase-1 -- analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.